MacroGenics, Inc. (MGNX) Social Stream



MacroGenics, Inc. (MGNX): $3.73

-0.23 (-5.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MGNX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Macrogenics Inc (MGNX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Macrogenics Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 9 $50 $17 $37.5 $9.54 293.08%
2021-11-17 8 $50 $30 $40.428 $9.54 323.77%
2022-02-07 9 $50 $30 $40.375 $9.54 323.22%
2022-02-11 10 $50 $30 $39.333 $9.54 312.3%
2022-02-24 10 $50 $23 $35.444 $9.54 271.53%
2022-02-28 10 $50 $21 $33.333 $9.54 249.4%

The Trend in the Analyst Price Target


MGNX's average price target has moved down $3.56 over the prior 38 weeks.

MGNX reports an average of 108.36% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 7 40 16 33.800 34.80 -2.87%
2021-06-13 12 50 17 37.000 21.33 73.46%
2021-08-07 12 50 17 36.890 24.54 50.33%
2021-09-11 12 50 17 36.890 25.10 46.97%
2022-02-28 11 50 21 33.333 9.35 256.5%

MGNX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 10 0 0 0 0 10

The Trend in the Broker Recommendations


Over the past 19 months, MGNX's average broker recommendation rating improved by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MGNX as an investment opportunity.

  • Macrogenics Inc's upside potential (average analyst target price relative to current price) is higher than 736.58% of all US stocks.
  • MGNX has a lower variance in analysts' estimates than -517.04% of all US stocks.
  • Macrogenics Inc's number of analysts covering the stock is greater than 623.34% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, Macrogenics Inc's average analyst price target is greater than 475.75% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Macrogenics Inc are ME, MDGL, and MCRB.

What is the outlook for MGNX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6229 seconds.